BBC NEWS Americas Africa Europe Middle East South Asia Asia Pacific Arabic Spanish Russian Chinese Welsh

 You are in: Health
Front Page 
UK Politics 
Background Briefings 
Medical notes 
Talking Point 
In Depth 

Commonwealth Games 2002

BBC Sport

BBC Weather

Wednesday, 10 October, 2001, 23:02 GMT 00:02 UK
Children's 'lifeblood' hope
Alison Farrow and her brother Matthew
Alison Farrow and her brother Matthew
Children who needed transplants to provide key stem cells previously had to hope they could find a bone marrow donor with which they were compatible.

But the BBC's Horizon programme details how blood from babies' umbilical cords can offer hope to many children.

Matthew Farrow was a world first.

Now a healthy teenager, he was born with the rare blood disorder Fanconi's Anaemia, and was expected to die before he was 10.

When he was five, his parents were told another baby could provide the bone marrow containing healthy stem cells needed to treat his condition.

Stem cells as they divide
Stem cells as they divide
But Matthew was too ill to wait a year until his sister was old enough to act as bone donor.

Instead, his parents agreed to take part in a pioneering experiment to use stem cells from his sister's umbilical cord.

After Alison's birth in February 1998, Matthew's diseased blood stem cells were eradicated with chemotherapy, then his sister's cord blood was infused straight into his blood.

Since this successful operation, thousands of children around the world have been helped by the procedure.

Nineteen such operations have taken place in the UK on children with leukaemia. Just over half have been successful.

Much of the work has centred at Duke University Medical Center, in North Carolina, USA.

Cord blood hope

Stem cells are master cells that have the ability to develop into any of the body's tissue types, such as blood, liver, muscle and other cells.

In the past, bone marrow transplants were the only source of stem cells for seriously ill children with blood disorders.

Half a cup-full of cord blood might provide us with enough stem cells to save a child

Professor Hal Broxmeyer, Indiana University School of Medicine
Patients who undergo bone marrow transplants have to be a genetic match with the donor on a 12-point scale - a so-called "perfect match".

Any bone marrow which is not perfect runs the risk of being rejected by the recipient's system - which can be fatal.

The world-wide bone marrow register has 7m names on it, but a third of cases cannot be helped by it.

But they could be helped by blood from umbilical cord, so-called "cord blood".

Dr Joanne Kurtzberg, the doctor who has led the cord blood transplant programme at Duke University Hospital, said: "Cord blood might not just be an alternative [to bone marrow], it might even be better because cord blood doesn't need a prefect match."

She estimated it could help in 90% of cases, where bone marrow could not help.

The attraction of cord blood, say doctors, is that the match does not have to be so close - meaning many more children can be treated.

However, children are still at risk after the core blood transplant.

Because they are waiting for the implanted stem cells to ingraft, or "take", they are left without an effective immune system, leaving them open to infection.

The treatment was first developed by Professor Hal Broxmeyer at Indiana University School of Medicine.

Tests found despite a much smaller quantity of cord blood compared to the litre of bone marrow that was usually transplanted, there were more stem cells in the cord blood.

"That half a cup-full of cord blood might provide us with enough stem cells to save a child," he said.


Lidel Pressey is one of those who was offered a last chance by a core blood transplant.

Lidel Pressey, treated with a cord blood transplant
Lidel Pressey, treated with a cord blood transplant
The little boy had been unable to find a donor because he was of mixed race, and had an unusual genetic make-up.

Two weeks after his transplant, the stem cells had ingrafted, and just weeks after his operation, he was able to go home.

Professor Broxmeyer is now leading work into using cord blood to treat adults with blood diseases.

But the amount of stem cells in the cord blood is insufficient to treat adults, so his team is trying to use growth factors to create enough cord blood.

Initial trials have proved successful in two out of 20 patients treated.

Horizon will be transmitted on BBC2 on Thursday 11 October at 21.00 BST.

See also:

08 Sep 01 | Health
Banking on a healthy future
10 Aug 01 | Sci/Tech
Stem cells: Q & A
03 May 01 | Health
'Super stem cell' tested in mice
Internet links:

The BBC is not responsible for the content of external internet sites

Links to more Health stories are at the foot of the page.

E-mail this story to a friend

Links to more Health stories